{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32851075", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "10"}], "Language": ["eng"], "ELocationID": ["4638132", "10.1155/2020/4638132"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Preclinical Development of Mahanine-Enriched Fraction from Indian Spice <i>Murraya koenigii</i> for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies.", "Pagination": {"StartPage": "4638132", "MedlinePgn": "4638132"}, "Abstract": {"AbstractText": ["<i>Murraya koenigii</i> is well documented in the Indian ancient medical text \"Charaka Samhita.\" The carbazole alkaloid \"mahanine\" from this plant exhibited anticancer activity against several cancers. Here, we have taken a comprehensive study to standardize the method for the preparation of a mahanine-enriched fraction (MEF) with the highest yield and defined markers. Our optimized method produced MEF having the highest amount of mahanine, a major marker, with excellent <i>in vitro</i> antiproliferative activity against ovarian and breast cancer cells as evidenced by decreased cell viability by MTT assay. Moreover, it exhibited condensed and fragmented nuclei by DAPI staining and increased annexin V-/PI-stained cells after MEF treatment, indicating apoptosis. It also exhibited good efficacy in ovarian and breast cancer syngeneic mice models, with an ED50 of 300\u2009mg/kg body weight (BW). MEF is stable up to 40\u00b0C for \u22653 months. Its biological activity remains unchanged at a wide range of pH (1-10) for up to ~3 hours, indicating a safe oral route of administration. Additionally, the comparative pharmacokinetics of MEF and mahanine in rats showed a 31% higher bioavailability of mahanine in MEF-fed rats compared to rats fed with mahanine alone. Furthermore, mice fed with MEF at 5000\u2009mg/kg BW single dose, 300-1500\u2009mg/kg BW/day for 14 days, and 300\u2009mg/kg BW/day for 28, 90, and 180 days for subacute, subchronic, chronic studies, respectively, did not show any significant clinical signs of toxicity, behavioral changes, mortality, organ weights, serum biochemistry, and hematological parameters indicating no/minimum toxicity for up to 180 days. To the best of our knowledge, this is the first report showing the pH/temperature stability and chronic toxicity studies of MEF along with <i>in vivo</i> efficacy against breast cancer. Taken together, our study will enhance the commercial value of this highly potential medicinal plant and will be helpful as a reference material for its clinical development."], "CopyrightInformation": "Copyright \u00a9 2020 Eswara Murali Satyavarapu et al."}, "AuthorList": [{"Identifier": ["0000-0003-4532-962X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, 4, Raja S.C. Mallick Road, Kolkata 700032, India."}], "LastName": "Satyavarapu", "ForeName": "Eswara Murali", "Initials": "EM"}, {"Identifier": ["0000-0002-2209-4138"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, 4, Raja S.C. Mallick Road, Kolkata 700032, India."}], "LastName": "Sinha", "ForeName": "Prasun Kumar", "Initials": "PK"}, {"Identifier": ["0000-0001-8275-3978"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, 4, Raja S.C. Mallick Road, Kolkata 700032, India."}], "LastName": "Mandal", "ForeName": "Chitra", "Initials": "C"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Carbazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "mahanine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["adverse effects", "chemistry", "pharmacology"], "DescriptorName": "Carbazoles"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Murraya"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Pharmacokinetics"}, {"QualifierName": ["adverse effects", "chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["adverse effects", "analysis"], "DescriptorName": "Spices"}], "CoiStatement": "All the authors declare no financial and nonfinancial competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pan S. Y., Zhou S. F., Gao S. H., et al. New perspectives on how to discover drugs from herbal medicines: CAM\u2019s outstanding contribution to modern therapeutics. Evidence-Based Complementary and Alternative Medicine: eCAM. 2013;2013, article 627375:25. doi: 10.1155/2013/627375.", "ArticleIdList": ["10.1155/2013/627375", "PMC3619623", "23634172"]}, {"Citation": "Zhang J., Onakpoya I. J., Posadzki P., Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evidence-Based Complementary and Alternative Medicine : eCAM. 2015;2015, article 316706:3. doi: 10.1155/2015/316706.", "ArticleIdList": ["10.1155/2015/316706", "PMC4370194", "25838831"]}, {"Citation": "Bhatt A. Phytopharmaceuticals: a new drug class regulated in India. Perspectives in Clinical Research. 2016;7(2):59\u201361. doi: 10.4103/2229-3485.179435.", "ArticleIdList": ["10.4103/2229-3485.179435", "PMC4840792", "27141470"]}, {"Citation": "Yang L., Wen K. S., Ruan X., Zhao Y. X., Wei F., Wang Q. Response of plant secondary metabolites to environmental factors. Molecules. 2018;23(4):p. 762. doi: 10.3390/molecules23040762.", "ArticleIdList": ["10.3390/molecules23040762", "PMC6017249", "29584636"]}, {"Citation": "Shah R. K., Das L., Sangma G. Medicinal property of Murraya koenigii\u2014a review. International Research Journal of Biological Sciences. 2013;2(9):80\u201383."}, {"Citation": "Samanta S. K., Dutta D., Roy S., et al. Mahanine, a DNA minor groove binding agent exerts cellular cytotoxicity with involvement of C-7-OH and \u2212NH functional groups. Journal of Medicinal Chemistry. 2013;56(14):5709\u20135721. doi: 10.1021/jm400290q.", "ArticleIdList": ["10.1021/jm400290q", "23829449"]}, {"Citation": "Bhattacharya K., Samanta S. K., Tripathi R., et al. Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochemical Pharmacology. 2010;79(3):361\u2013372. doi: 10.1016/j.bcp.2009.09.007.", "ArticleIdList": ["10.1016/j.bcp.2009.09.007", "19751707"]}, {"Citation": "Bhattacharya K., Bag A. K., Tripathi R., et al. Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme. American Journal of Cancer Research. 2014;4(6):629\u2013647.", "ArticleIdList": ["PMC4266700", "25520856"]}, {"Citation": "Maiti S., Mondal S., Satyavarapu E. M., Mandal C. mTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation. Cell Death & Disease. 2017;8(7, article e2926) doi: 10.1038/cddis.2017.296.", "ArticleIdList": ["10.1038/cddis.2017.296", "PMC5550848", "28703798"]}, {"Citation": "Satyavarapu E. M., Das R., Mandal C., Mukhopadhyay A., Mandal C. Autophagy-independent induction of LC3B through oxidative stress reveals its non-canonical role in anoikis of ovarian cancer cells. Cell Death and Disease. 2018;9(10):p. 934. doi: 10.1038/s41419-018-0989-8.", "ArticleIdList": ["10.1038/s41419-018-0989-8", "PMC6141567", "30224639"]}, {"Citation": "Das R., Bhattacharya K., Samanta S. K., Pal B. C., Mandal C. Improved chemosensitivity in cervical cancer to cisplatin: synergistic activity of mahanine through STAT3 inhibition. Cancer Letters. 2014;351(1):81\u201390. doi: 10.1016/j.canlet.2014.05.005.", "ArticleIdList": ["10.1016/j.canlet.2014.05.005", "24831030"]}, {"Citation": "Das R., Bhattacharya K., Sarkar S., Samanta S. K., Pal B. C., Mandal C. Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma. Apoptosis. 2014;19(1):149\u2013164. doi: 10.1007/s10495-013-0907-6.", "ArticleIdList": ["10.1007/s10495-013-0907-6", "24052409"]}, {"Citation": "Roy S., Dutta D., Satyavarapu E. M., et al. Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis. Scientific Reports. 2017;7(1):p. 4141. doi: 10.1038/s41598-017-03943-y.", "ArticleIdList": ["10.1038/s41598-017-03943-y", "PMC5482887", "28646156"]}, {"Citation": "Satyavarapu E. M., Sinha P. K., Mandal C. Influence of geographical and seasonal variations on carbazole alkaloids distribution in Murraya koenigii: deciding factor of its in vitro and in vivo efficacies against cancer cells. Biomed Research International. 2020;2020:12. doi: 10.1155/2020/7821913.7821913", "ArticleIdList": ["10.1155/2020/7821913", "PMC7036096", "32104704"]}, {"Citation": "Dhandapani B., Eswara M. S., Susrutha N., et al. Spectrophotometric estimation of meloxicam in bulk and its pharmaceutical formulations. International Journal of Pharma Sciences and Research (IJPSR) 2010;1:217\u2013221."}, {"Citation": "Raghuvanshi D., Nkepang G., Hussain A., Yari H., Awasthi V. Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method. Journal of Pharmaceutical Analysis. 2017;7(1):1\u20139. doi: 10.1016/j.jpha.2016.09.004.", "ArticleIdList": ["10.1016/j.jpha.2016.09.004", "PMC5686864", "29404012"]}, {"Citation": "Hussain K., Ismail Z., Sadikun A., Ibrahim P. Bioactive markers based pharmacokinetic evaluation of extracts of a traditional medicinal plant, Piper sarmentosum. Evidence-based Complementary and Alternative Medicine. 2011;2011:8. doi: 10.1093/ecam/nep143.980760", "ArticleIdList": ["10.1093/ecam/nep143", "PMC3137875", "19770264"]}, {"Citation": "Khan I. A., Singh A., Mindala D. P., et al. Preclinical development of gastro-protective botanical candidate from Woodfordia fruticosa(Linn.) Kurz: Chemical standardization, efficacy, pharmacokinetics and safety pharmacology. Journal of Ethnopharmacology. 2019;241:p. 112023. doi: 10.1016/j.jep.2019.112023.", "ArticleIdList": ["10.1016/j.jep.2019.112023", "31195031"]}, {"Citation": "Hou S., Liu Y., Kong Y., Brown M. L. Total synthesis of 7-hydroxymurrayazolinine, murrayamine D, and mahanine viam-nitro group activated pyran annulation. Organic Letters. 2015;17(10):2298\u20132301. doi: 10.1021/acs.orglett.5b00422.", "ArticleIdList": ["10.1021/acs.orglett.5b00422", "25919697"]}, {"Citation": "Anders C. K., Johnson R., Litton J., Phillips M., Bleyer A. Breast cancer before age 40 years. Seminars in Oncology. 2009;36(3):237\u2013249. doi: 10.1053/j.seminoncol.2009.03.001.", "ArticleIdList": ["10.1053/j.seminoncol.2009.03.001", "PMC2894028", "19460581"]}, {"Citation": "Perez E. A. Paclitaxel in breast cancer. The Oncologist. 1998;3(6):373\u2013389. doi: 10.1634/theoncologist.3-6-373.", "ArticleIdList": ["10.1634/theoncologist.3-6-373", "10388129"]}, {"Citation": "Sachan A. K., Kumar A. Stability testing of herbal products. Journal of Chemical and Pharmaceutical Research. 2015;7(12):511\u2013514."}, {"Citation": "Bajaj S., Singla D., Sakhuja N. Stability testing of pharmaceutical products. Journal of Applied Pharmaceutical Science. 2012;2(3):129\u2013138."}, {"Citation": "Sun M., Li D., Wang X., et al. Intestine-penetrating, pH-sensitive and double-layered nanoparticles for oral delivery of doxorubicin with reduced toxicity. Journal of Materials Chemistry B. 2019;7(23):3692\u20133703. doi: 10.1039/C9TB00212J.", "ArticleIdList": ["10.1039/C9TB00212J"]}, {"Citation": "Manallack D. T., Prankerd R. J., Yuriev E., Oprea T. I., Chalmers D. K. The significance of acid/base properties in drug discovery. Chemical Society Reviews. 2013;42(2):485\u2013496. doi: 10.1039/c2cs35348b.", "ArticleIdList": ["10.1039/c2cs35348b", "PMC3641858", "23099561"]}, {"Citation": "Goldman P. Effect of bioavailability on dose-response relationships. The American Journal of Medicine. 1984;77(5):47\u201351. doi: 10.1016/S0002-9343(84)80007-8.", "ArticleIdList": ["10.1016/S0002-9343(84)80007-8", "6496559"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "3", "Day": "19"}, {"Year": "2020", "Month": "6", "Day": "23"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["32851075", "PMC7439207", "10.1155/2020/4638132"]}}], "PubmedBookArticle": []}